{
    "eid": "2-s2.0-84983311786",
    "title": "Intravenous versus oral dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in patients with primary ovarian, fallopian tube and peritoneal cancer: A double-blind randomized controlled trial",
    "cover-date": "2016-09-01",
    "subject-areas": [
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "dexamethasone",
        "hypersensitivity reaction",
        "ovarian cancer",
        "paclitaxel"
    ],
    "authors": [
        "Marut Yanaranop"
    ],
    "citedby-count": 15,
    "ref-count": 23,
    "ref-list": [
        "Global cancer statistics, 2012",
        "2004 consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)",
        "Hypersensitivity reactions from taxol",
        "Paclitaxel (Taxol)",
        "Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity",
        "Prophylaxis for paclitaxel hypersensitivity reactions",
        "Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy",
        "Phase I Clinical and Pharmacokinetic Study of Taxol",
        "Short-course intravenous prophylaxis for paclitaxel-telated hypersensitivity reactions",
        "Intravenous versus oral dexamethasone premedication in preventing paclitaxel infusion hypersensitivity reactions in gynecological malignancies",
        "Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel [3]",
        "Single-dose dexamethasone paclitaxel premedication",
        "An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions",
        "A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel",
        "A simplified premedication schedule for 1-hour paclitaxel administration",
        "A simplified premedication protocol for one-hour paclitaxel infusion in various combinations",
        "CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials",
        "Common Terminology Criteria for Adverse Events v.4.03 (CTCAE)",
        "Side effects of corticosteroid therapy",
        "Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian",
        "Interim analysis: The alpha spending function approach",
        "Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum",
        "Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: A comparison with dexamethasone phosphate (DP)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "affilname": "Rangsit University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Rajavithi Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}